Correlation Between PT Astra and Aslan Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both PT Astra and Aslan Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT Astra and Aslan Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PT Astra International and Aslan Pharmaceuticals, you can compare the effects of market volatilities on PT Astra and Aslan Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT Astra with a short position of Aslan Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT Astra and Aslan Pharmaceuticals.

Diversification Opportunities for PT Astra and Aslan Pharmaceuticals

-0.6

Correlation Coefficient

PT Astra  Aslan Pharmaceuticals

Excellent diversification

The 3 months correlation between PTAIF and Aslan is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding PT Astra International and Aslan Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aslan Pharmaceuticals and PT Astra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT Astra International are associated (or correlated) with Aslan Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aslan Pharmaceuticals has no effect on the direction of PT Astra i.e., PT Astra and Aslan Pharmaceuticals go up and down completely randomly.

Pair Corralation between PT Astra and Aslan Pharmaceuticals

Assuming the 90 days horizon PT Astra International is expected to generate 0.59 times more return on investment than Aslan Pharmaceuticals. However, PT Astra International is 1.69 times less risky than Aslan Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Aslan Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest  36.00  in PT Astra International on September 4, 2024 and sell it today you would earn a total of  1.00  from holding PT Astra International or generate 2.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	78.5%
Values	Daily Returns

PT Astra International  vs.  Aslan Pharmaceuticals

PT Astra International

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in PT Astra International are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating forward indicators, PT Astra reported solid returns over the last few months and may actually be approaching a breakup point.

Aslan Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aslan Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Aslan Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with PT Astra and Aslan Pharmaceuticals

The main advantage of trading using opposite PT Astra and Aslan Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT Astra position performs unexpectedly, Aslan Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aslan Pharmaceuticals will offset losses from the drop in Aslan Pharmaceuticals' long position.

The idea behind PT Astra International and Aslan Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.